This inventor holds 1 USPTO granted patent. Top assignee: Glycorex Ab. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Gregor Kuznik: Innovator in Anti-inflammatory Compounds
Introduction
Gregor Kuznik is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory compounds. His work focuses on creating innovative solutions to combat diseases associated with increased cell-cell adhesion.
Latest Patents
Gregor Kuznik holds a patent for "Anti-inflammatory cell adhesion inhibitors." This invention relates to compounds of formula Ix and Ia, wherein (Ix) comprises the regioisomeric form sLe.sup.X and (Ia) comprises the regioisomeric form sLe.sup.A. R.sup.1 is a lipophilic radical formed from aliphatic or cycloaliphatic units, or a sugar residue capped by a .beta.1-O-linked aliphatic or cycloaliphatic unit at the reducing end of the terminal sugar. The compounds are useful as inhibitors of increased cell-cell adhesion and are incorporated into pharmaceutical compositions for treating related diseases. He has 1 patent to his name.
Career Highlights
Gregor Kuznik is associated with Glycorex AB, where he continues to advance his research and development efforts. His work has the potential to significantly impact the pharmaceutical industry by providing new therapeutic options for patients suffering from inflammatory conditions.
Collaborations
He has collaborated with notable colleagues such as Carlo Unverzagt and Gerhard Kretzschmar, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Gregor Kuznik is a prominent figure in the field of anti-inflammatory research, with a focus on developing compounds that can effectively inhibit cell adhesion. His contributions are paving the way for new treatments in the pharmaceutical industry.